Advertisement

Topics

GSK R&D president Patrick Vallance to become UK Government's chief scientific adviser

08:25 EST 10 Nov 2017 | PharmaBiz

GlaxoSmithKline has announced that Dr Patrick Vallance, president, R&D, has informed the board of his intention to leave the company to become the UK Government's Chief Scientific Adviser and Head of the Government's Office for Science.

Original Article: GSK R&D president Patrick Vallance to become UK Government's chief scientific adviser

NEXT ARTICLE

More From BioPortfolio on "GSK R&D president Patrick Vallance to become UK Government's chief scientific adviser"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...